Navigation Links
Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure

PHILADELPHIA -- The Center of Excellence in Environmental Toxicology (CEET) at the University of Pennsylvania School of Medicine has been awarded $2.3 million over the next four years to study biological indicators of exposure to cigarette smoke. The grant is part of the National Institutes of Health new Genes, Environment, and Health Initiative (GEI). The GEI represents a unique collaboration between geneticists and environmental health scientists. In this first round of awards genetic studies were funded by the National Human Genome Research Institute and biomarker studies were funded by the National Institute of Environmental Health Sciences.

Exposure to tobacco smoke both mainstream and second-hand is a leading cause of death in the United States. Cigarette smoke contains about 3,800 chemical constituents, including polycyclic aromatic hydrocarbons (PAHs), which can cause lung, skin, and bladder cancer. Whats more, tobacco smoke is associated with cardiovascular disease, chronic obstructive pulmonary disease, and pancreatic disease, and is likely responsible for more deaths than any other environmental exposure.

Only one in ten smokers get lung cancer, but the five-year survival rate after diagnosis is only 15 percent, says Trevor M. Penning, PhD, CEETs director. The question is, how can we intervene earlier to identify people most at risk. We aim to look at the interaction of genetic susceptibility to lung cancer and biomarkers of exposure to cigarette smoke. At the end of the day, if we study genetics and exposure together, well hopefully have a very strong statement to say who is most at risk.

This could be like measuring cholesterol for preventing heart disease, says principal investigator Ian Blair, PhD, Professor and Vice Chair of the Department of Pharmacology. If, for example, a certain chemical change is seen in a smokers DNA, it might inspire them to give up smoking. You could show them a biomarker panel and say, Heres your DNA on smoking and heres DNA without smoking. This is my vision. Blair is also the Director of Penns Center for Cancer Pharmacology.

The researchers propose to screen smokers, non-smokers and those regularly in contact with second-hand smoke for a variety of biochemical markers. Previous studies have shown that chemical changes arise within the body, from the tissue level down to the DNA level in people who smoke or who have been exposed to smoke, but this association has never been studied on a large scale with reliable biomarkers.

The plan is to develop a panel of biochemicals, or biomarkers, that indicate if a person has been exposed to smoke to then distinguish between a group of non-smokers and disease-free tobacco smokers. They will test for the presence of these chemicals in smokers blood, urine, and breath. These studies will provide important base-line data for subsequent studies that will relate cigarette smoke exposure to incidence and genetic susceptibility to tobacco-related disease of the lung and cardiovascular system.

The Penn program has already implemented patient recruitment through the participation of Anil Vachani, MD, Assistant Professor of Medicine. It is anticipated that substantial new information will become available on the presence of various biomarkers so that Andrea Troxel, PhD, Associate Professor of Biostatistics, can assess their potential utility. In addition to determining conventional lipid and DNA biomarkers, a discovery program will be implemented in collaboration with Don Baldwin, PhD, Director of the Penn Microarray Core Facility, in order to identify potential protein biomarkers.

The Principal Investigators from each of the funded projects in the GEI will meet at the National Institutes of Health in December 2007 so that the projects can benefit from the individual expertise of the various participants. Annual meetings between the investigators will then take place over the course of the four years of funded research. It is anticipated that panels of new biomarkers will emerge from these meetings and that the biomarkers will prove to be critical for future studies designed to monitor the adverse effects of gene-environment interactions.

The Penn studies will be complimentary to an earlier award made by the Pennsylvania Department of Health to the CEET, which aims to identify lung cancer susceptibility genes in smokers.


Contact: Karen Kreeger
University of Pennsylvania School of Medicine

Related medicine news :

1. School Children Put To Risk Due To Shortage Of Nurses
2. Schools and Bars closed in Rwanda due to Cholera outbreak
3. Does Success in School Differ From the Real World Success ?
4. Preschoolers eat more when served in bigger helpings
5. Watching TV in the bedroom can lower children’s school performanc
6. Exposure to Pesticides in Schools Produces Illnesses Among Employees, Students
7. Adolescents Who Walk To School Are Fitter, More Active
8. Safe Neighborhood Means Less TV For Preschool Children
9. Popularity Among Peers Increases Susceptibility To Smoking Habit Among School Children
10. Vitamin filled nutrition candy for School children
11. Fish Oil supplementation reduces physical aggression in school children’
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: